* Offers 2.2 mln shares at $7.50 each
* Shares fall 11 percent
June 30 (Reuters) - Mela Sciences Inc MELA.O said it would sell about 2.2 million common shares at $7.50 each, an 11 percent discount to the stock's closing price Tuesday.
The company plans to use the proceeds to fund the pre-market approval application for its skin cancer screening device, MelaFind.
The offering, with an over-allotment option of 330,000 shares, is expected to close on July 6, Mela said in a statement.
Needham & Company LLC and Leerink Swann LLC are acting as joint book-running managers for the offering.
Shares of the company were down about 9 percent at $7.56 in morning trade Wednesday on Nasdaq. They touched a low of $7.40 in early trade. (Reporting by Krishnakali Sengupta in Bangalore; Editing by Gopakumar Warrier)
Our Standards: The Thomson Reuters Trust Principles.